doi:10.1007/s12250-011-3183-z

[1]
Li He, Aiping Zang, Min Du, Dapeng Ma, Chuanping Yuan, Chun Zhou, Jing Mu, Huanjing Shi, Dapeng Li, Xulin Huang, Qiang Deng, Jianhua Xiao, Huimin Yan, Lijian Hui, Ke Lan, Sidong Xiong, Xiaoxia Li, Zhong Huang, Hui Xiao, 2015: mTOR regulates TLR-induced c-fos and Th1 responses to HBV and HCV vaccines, Virologica Sinica, 30, 174-189. doi: 10.1007/s12250-015-3606-3
[2]
Julian Ruiz-Sáenz, Jairo Jaime, Victor Vera, 2013: An Inactivated Vaccine from a Field Strain of Bovine Herpesvirus-1 (BoHV-1) has High Antigenic Mass and Induces Strong Efficacy in a Rabbit Model, Virologica Sinica, 28, 36-42. doi: 10.1007/s12250-013-3283-z
[3]
Yu-xuan HOU, Cheng PENG, Zheng-gang HAN, Peng ZHOU, Ji-guo CHEN, Zheng-li SHI, 2010: Immunogenicity of the Spike Glycoprotein of Bat SARS-like Coronavirus, Virologica Sinica, 25, 36-44. doi: 10.1007/s12250-010-3096-2
[4]
Ning Luan, Han Cao, Yunfei Wang, Kangyang Lin, Cunbao Liu, 2022: LNP-CpG ODN-adjuvanted varicella-zoster virus glycoprotein E induced comparable levels of immunity with Shingrix^TM in VZV-primed mice, Virologica Sinica, 37, 731-739. doi: 10.1016/j.virs.2022.06.002
[5]
Jiajie Wei, Jonathan W. Yewdell, 2019: Flu DRiPs in MHC Class Ⅰ Immunosurveillance, Virologica Sinica, 34, 162-167. doi: 10.1007/s12250-018-0061-y
[6]
Chuan-hai ZHANG, Xin-jian LIU, Yi-fei WANG, Jia-hai LU, Huan-ying ZHENG, Sheng XIONG, Mei-ying ZHANG, Qiu-ying LIU, 2007: Immune Responses and Histopathological Changes in Rabbits Immunized with Inactivated SARS Coronavirus*, Virologica Sinica, 22, 360-365.
[7]
Yuming Li, Yanhong Tang, Xiaoqian Wang, Airu Zhu, Dongdong Liu, Yiyun He, Hu Guo, Jie Zheng, Xinzhuo Liu, Fengyu Chi, Yanqun Wang, Zhen Zhuang, Zhaoyong Zhang, Donglan Liu, Zhao Chen, Fang Li, Wei Ran, Kuai Yu, Dong Wang, Liyan Wen, Jianfen Zhuo, Yanjun Zhang, Yin Xi, Jingxian Zhao, Jincun Zhao, Jing Sun, 2024: Characterization of humoral immune responses against SARS-CoV-2 accessory proteins in infected patients and mouse model, Virologica Sinica, 39, 414-421. doi: 10.1016/j.virs.2024.04.005
[8]
Yongmei Liu, Jianhua Lu, Haoting Zhan, Wenfang Yuan, Xiaomeng Li, Haiyan Kang, Haolong Li, Yongliang Chen, Linlin Cheng, Xingli Sun, Haojie Zheng, Wei Wang, Erhei Dai, Yongzhe Li, 2023: Inactivated SARS-CoV-2 booster vaccine enhanced immune responses in patients with chronic liver diseases, Virologica Sinica, 38, 723-734. doi: 10.1016/j.virs.2023.07.005
[9]
Yang Zheng, Qing Zhang, Ashaq Ali, Ke Li, Nan Shao, Xiaoli Zhou, Zhiqin Ye, Xiaomin Chen, Shanshan Cao, Jing Cui, Juan Zhou, Dianbing Wang, Baidong Hou, Min Li, Mengmeng Cui, Lihua Deng, Xinyi Sun, Qian Zhang, Qinfang Yang, Yong li, Hui Wang, Yake Lei, Bo Yu, Yegang Cheng, Xiaolin Tong, Dong Men, Xian-En Zhang, 2021: Sustainability of SARS-CoV-2 Induced Humoral Immune Responses in COVID-19 Patients from Hospitalization to Convalescence Over Six Months, Virologica Sinica, 36, 869-878. doi: 10.1007/s12250-021-00360-4
[10]
Jiang-Fan Li, Lei He, Yong-Qiang Deng, Shu-Hui Qi, Yue-Hong Chen, Xiao-Lu Zhang, Shi-Xiong Hu, Rui-Wen Fan, Guang-Yu Zhao, Cheng-Feng Qin, 2021: Generation and Characterization of a Nanobody Against SARS-CoV, Virologica Sinica, 36, 1484-1491. doi: 10.1007/s12250-021-00436-1
[11]
Xiuli Shen, Shuhui Wang, Yanling Hao, Yuyu Fu, Li Ren, Dan Li, Wenqi Tang, Jing Li, Ran Chen, Meiling Zhu, Shuo Wang, Ying Liu, Yiming Shao, 2024: DNA vaccine prime and replicating vaccinia vaccine boost induce robust humoral and cellular immune responses against MERS-CoV in mice, Virologica Sinica, 39, 490-500. doi: 10.1016/j.virs.2024.05.005
[12]
Lirong Liu, Wenhui Fan, He Zhang, Shuang Zhang, Liang Cui, Meng Wang, Xiaoyuan Bai, Wenxian Yang, Lei Sun, Limin Yang, Wenjun Liu, Jing Li, 2019: Interferon as a Mucosal Adjuvant for an Influenza Vaccine in Pigs, Virologica Sinica, 34, 324-333. doi: 10.1007/s12250-019-00102-7
[13]
Ashutosh Singh, Rahul Soloman Singh, Phulen Sarma, Gitika Batra, Rupa Joshi, Hardeep Kaur, Amit Raj Sharma, Ajay Prakash, Bikash Medhi, 2020: A Comprehensive Review of Animal Models for Coronaviruses: SARS-CoV-2, SARS-CoV, and MERS-CoV, Virologica Sinica, 35, 290-304. doi: 10.1007/s12250-020-00252-z
[14]
Jingyi Yang, Ejuan Zhang, Maohua Zhong, Qingyu Yang, Ke Hong, Ting Shu, Dihan Zhou, Jie Xiang, Jianbo Xia, Xi Zhou, Dingyu Zhang, Chaolin Huang, You Shang, Huimin Yan, 2020: Longitudinal Characteristics of T Cell Responses in Asymptomatic SARS-CoV-2 Infection, Virologica Sinica, 35, 838-841. doi: 10.1007/s12250-020-00277-4
[15]
Yajing Fu, Yuanxiong Cheng, Yuntao Wu, 2020: Understanding SARS-CoV-2-Mediated Inflammatory Responses: From Mechanisms to Potential Therapeutic Tools, Virologica Sinica, 35, 266-271. doi: 10.1007/s12250-020-00207-4
[16]
Hongming Huang, Jia Liu, 2023: Role of inactivated SARS-CoV-2 vaccine induced T cell responses in ameliorating COVID-19 severity, Virologica Sinica, 38, 324-326. doi: 10.1016/j.virs.2023.02.003
[17]
张珈敏, 郑从义, 胡远扬*, 2003: Morphology and Its M orphogenesis of the SARS-CoV Hb Strain in vitro, Virologica Sinica, 18, 404-406.
[18]
彭宇, 李姝, 李朝阳, 王菁菁, 田波, 郭德银*, 2005: Interaction between Nucleocapsid Protein and the Leader the Sequence of SARS-CoV RNA, Virologica Sinica, 20, 490-493.
[19]
黄欣, 高亚萍, 王希良, 辛忠涛, 董洁, 邵宁生, 柳川, 2006: Screening and Identification of the SARS-CoV N Protein Epitopes, Virologica Sinica, 21, 314-318.
[20]
赵琳, 涂亦娴, 于杨, 金华利, 陈则, 王宾, 2006: Role of ORF7 in the Genome of SARS-CoV, Virologica Sinica, 21, 343-347.